Estimating the global burden of snakebite can help to improve management

[...]there is little financial incentive for pharmacists and health centres to sell antivenom because they reap only feeble profit margins. [...]there are no comprehensive data on how many doses of antivenom are required and where they should be distributed.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2008-11, Vol.5 (11), p.e221
1. Verfasser:	Chippaux, Jean-Philippe
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antivenins Antivenins - therapeutic use Bites and stings Care and treatment Critical Care and Emergency Medicine Drug dosages Drugs and adverse drug reactions Economic aspects Emergency Medicine Global Health Health care Hospitals Humans Incidence Infectious Diseases Market size Medicine in Developing Countries Morbidity Pharmaceutical industry Prices and rates Public Health Public Health and Epidemiology Snake Bites - epidemiology Snake Bites - mortality Snakes Studies Supply and demand
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...]there is little financial incentive for pharmacists and health centres to sell antivenom because they reap only feeble profit margins. [...]there are no comprehensive data on how many doses of antivenom are required and where they should be distributed.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.0050221